1. 81 LONG-TERM OUTCOME OF LOWER RISK MDS PATIENTS RECEIVING ESA, AND IMPACT OF POST-ESA TREATMENTS ON SURVIVAL: A RETROSPECTIVE STUDY FROM THE GFM, DÜSSELDORF, AND GESMD REGISTRIES. (April 2015) Authors: Park, S.; Hamel, J.F.; Kelaidi, C.; Campelo, M. Diez; Schemenau, J.; Sapena, R.; Goetze, K.; Mueller-Thomas, K.; Beyne-Rauzy, O.; Stamatoullas, A.; Guerci-Bresler, A.; Cony-Makhoul, P.; Courby, S.; Cheze, S.; Rose, C.; Vey, N.; Germing, U.; Sanz, G.; Fenaux, P.; Dreyfus, F. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1186: A LARGE FRENCH REAL WORLD MULTICENTRIC PROSPECTIVE COHORT OF PATIENTS WITH LYMPHOMA (REALYSA STUDY): DESCRIPTION OF THE DIFFUSE LARGE B CELL LYMPHOMA PATIENTS IN REAL WORLD IN FRANCE. (23rd June 2022) Authors: Ghesquieres, H.; Cherblanc, F.; Belot, A.; Camus, V.; Thokagevistk, K.; Bouabdallah, K.-K.; Esnault, C.; Fornecker, L.-M.; Micon, S.; Bijou, F.; Haioun, C.; Morineau, N.; Ysebaert, L.; Damaj, G.; Le Gouill, S.; Guidez, S.; Morschhauser, F.; Thiéblemont, C.; Chauchet, A.; Gressin, R. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1072 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER-RISK MYELODYSPLASTIC SYNDROMES. (23rd June 2022) Authors: Kubasch, A. S.; Giagounidis, A.; Metzgeroth, G.; Jonasova, A.; Herbst, R.; Diaz, J. M. T.; De Renzis, B.; Götze, K. S.; Huetter-Kroenke, M.-L.; Gourin, M.-P.; Slama, B.; Dimicoli-Salazar, S.; Cony-Makhoul, P.; Laribi, K.; Park, S.; Jersemann, K.; Schipp, D.; Metzeler, K. H.; Tiebel, O.; Sockel, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗